Loading stock data...

Phaarmasia Limited

BSE: PHRMASI

BSE
93.00 -3.90 (-4.02%)

Prev Close

96.9

Open Price

96.9

Volume

355

Today Low / High

93 / 101.74

52 WK Low / High

23.6 / 131.75

Range

88 - 98

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 93, reflecting a change of -3.9 (-4.02477%). The expected target range on the BSE is 88 - 98. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 96.90 -4.02%
24 Feb 96.90 0.00%
20 Feb 99.00 3.02%
19 Feb 94.17 10.51%
18 Feb 99.12 0.00%
17 Feb 107.50 -2.95%
16 Feb 113.29 -3.06%
13 Feb 118.70 -2.61%
12 Feb 119.96 -1.05%
11 Feb 119.80 0.13%
10 Feb 114.25 0.00%
09 Feb 108.81 0.00%
06 Feb 99.19 4.48%
05 Feb 89.35 10.46%
04 Feb 94.05 0.00%
03 Feb 98.75 0.25%
02 Feb 99.00 0.00%
01 Feb 99.00 0.00%
30 Jan 99.00 0.00%
29 Jan 92.80 7.76%
28 Jan 97.65 0.00%

Phaarmasia Limited Graph

Phaarmasia Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Phaarmasia Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 93.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 93.00 93.93 84.54 - 103.32
94.86 75.89 - 113.83
95.79 67.05 - 124.53
Bearish Scenario 93.00 92.07 82.86 - 101.28
91.14 72.91 - 109.37
90.21 63.15 - 117.27

Overview of Phaarmasia Limited

ISIN

INE486I01016

Industry

Medical - Pharmaceuticals

Vol.Avg

3,431

Market Cap

634,907,280

Last Dividend

0

Official Website

Visit Website

IPO Date

2008-05-14

DCF Diff

91.13

DCF

4

Financial Ratios Every Investor Needs

Stock Rating Details for PHRMASI

Metric Value Recommendation
Overall Rating C Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 24.37 Cr 21.69 Cr 2.68 Cr 0.1100 0.00 Cr 1.94 Cr -2.33 Cr -1.59 Cr -2.32 -1.27 Cr -0.0652
2024-03-31 30.59 Cr 26.70 Cr 3.89 Cr 0.1271 0.00 Cr 0.16 Cr -1.16 Cr -0.52 Cr -0.76 -0.16 Cr -0.0169
2023-03-31 27.49 Cr 23.20 Cr 4.29 Cr 0.1561 0.00 Cr 0.14 Cr -1.90 Cr -1.26 Cr -1.84 -1.03 Cr -0.0458
2022-03-31 17.22 Cr 14.38 Cr 2.84 Cr 0.1647 0.00 Cr 0.10 Cr -2.03 Cr -1.55 Cr -2.27 -1.27 Cr -0.0899
2021-03-31 19.90 Cr 14.99 Cr 4.91 Cr 0.2468 0.00 Cr 0.17 Cr -0.40 Cr 0.31 Cr 0.46 0.83 Cr 0.0157

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.36 Cr 21.56 Cr 12.82 Cr 8.7359 Cr 0.01 Cr -0.35 Cr 3.06 Cr 12.29 Cr 0.00 Cr 0.00 Cr 0.06 Cr 12.6057 Cr
2024-03-31 0.49 Cr 31.45 Cr 21.15 Cr 10.2983 Cr 0.14 Cr -0.34 Cr 8.50 Cr 12.44 Cr 0.00 Cr 0.00 Cr -0.09 Cr 20.9138 Cr
2023-03-31 0.55 Cr 28.42 Cr 17.61 Cr 10.8098 Cr 0.27 Cr -0.28 Cr 6.36 Cr 12.73 Cr 0.03 Cr 0.00 Cr -0.09 Cr 17.2845 Cr
2022-03-31 0.08 Cr 21.21 Cr 9.15 Cr 12.0592 Cr 0.03 Cr -0.06 Cr 4.24 Cr 12.73 Cr 0.06 Cr 0.00 Cr 0.00 Cr 8.8791 Cr
2021-03-31 0.26 Cr 21.91 Cr 8.26 Cr 13.6527 Cr 0.05 Cr -0.21 Cr 2.63 Cr 13.02 Cr 0.81 Cr 0.22 Cr 0.00 Cr 7.8678 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.0275 Cr -0.1680 Cr -0.1293 Cr -0.1405 Cr -0.2696 Cr 0.3642 Cr -0.1680 Cr -1.5894 Cr -0.1293 Cr 0.0000 Cr 5.4430 Cr
2024-03-31 0.0948 Cr -0.0326 Cr -0.1185 Cr 0.0621 Cr -0.0565 Cr 0.6338 Cr -0.0326 Cr -0.5182 Cr -0.0063 Cr 0.0000 Cr -2.1448 Cr
2023-03-31 0.6499 Cr -0.0122 Cr -0.1624 Cr 0.6241 Cr 0.4752 Cr 0.6904 Cr -0.0258 Cr -1.4320 Cr -0.0228 Cr 0.0000 Cr -2.1117 Cr
2022-03-31 -0.1752 Cr 0.0078 Cr 0.0001 Cr -0.1752 Cr -0.1673 Cr 0.2152 Cr 0.0000 Cr -1.5621 Cr 0.0001 Cr 0.0000 Cr -1.6088 Cr
2021-03-31 0.2499 Cr 0.0000 Cr -0.0207 Cr 0.2499 Cr 0.2292 Cr 0.3825 Cr 0.0000 Cr 0.4787 Cr -0.0207 Cr 0.0000 Cr 3.4498 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 16.05 Cr 12.78 Cr 3.27 Cr 0.2038 0.78 Cr 16.27 Cr 23.84 19.99 Cr 1.0138
2025-09-30 16.55 Cr 10.49 Cr 6.06 Cr 0.3661 1.56 Cr 1.74 Cr 2.54 1.75 Cr 0.1049
2025-06-30 6.87 Cr 4.90 Cr 1.97 Cr 0.2870 0.02 Cr 0.27 Cr 0.40 0.40 Cr 0.0393
2025-03-31 5.43 Cr 4.89 Cr 0.54 Cr 0.0986 -0.70 Cr -0.53 Cr -0.77 -0.43 Cr -0.0967
2024-12-31 4.72 Cr 3.94 Cr 0.79 Cr 0.1664 -0.88 Cr -0.70 Cr -1.02 -0.60 Cr -0.1481

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.27 Cr 0.16 Cr 0.43 Cr 13.76 Cr 9.57 Cr 25.34 Cr 12.26 Cr 44.26 Cr 33.52 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -8.74 Cr
2025-03-31 0.36 Cr 0.00 Cr 0.36 Cr 3.11 Cr 3.06 Cr 8.21 Cr 12.29 Cr 21.56 Cr 12.82 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.38 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -9.93 Cr
2024-09-30 0.23 Cr 0.15 Cr 0.38 Cr 7.90 Cr 4.13 Cr 13.54 Cr 12.28 Cr 26.89 Cr 16.96 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2008-05-14 May 14, 08 1:5

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Chief Financial Officer
Eswara Vara Prasad Rao Nagineni

Gender: male

Year Born:

Whole-Time Director
Yallapragada Naga Bhaskara Rao

Gender: male

Year Born: 1963

Company Secretary & Compliance Officer
Urvashi Bhatia

Gender: female

Year Born:

FAQs about Phaarmasia Limited

Who is the CEO of the company?

The CEO is Yallapragada Naga Bhaskara Rao.

What is the current market price of the stock?

The current price is ₹93.00.

What is the 52-week price range?

The range is ₹23.6-131.75.

What is the market capitalization of the company?

The market capitalization is ₹63.49 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 3.58.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Phaarmasia Limited (ISIN: INE486I01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹63.49 crores and an average daily volume of 3,431 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.